Auxilio, Inc. Announces Payoff of Laurus Debt


MISSION VIEJO, Calif., April 9, 2009 (GLOBE NEWSWIRE) -- Auxilio, Inc. (OTCBB:AUXO), a provider of Document Services in Healthcare, is pleased to announce that we have paid in full the $3,000,000 convertible debt owed to Laurus Master Fund. The term of the debt was for three years and was paid on time and using cash generated from Auxilio's operational activity. "The convertible debt provided Auxilio with the necessary capital to implement three new large client contracts during 2006, as well as providing us with the financial resources to facilitate our company's general growth," stated Etienne Weidemann, President and CEO of Auxilio. "The settlement of the debt will significantly improve our balance sheet," added Mr. Weidemann.

About Auxilio, Inc.

Auxilio provides healthcare document services including situational analysis, strategy development and implementation. The company helps health systems streamline and align processes and infrastructure to create manageable, dependable document management programs that reduce cost and increase productivity. Auxilio's Image Management programs guarantee our clients immediate measurable savings, a fully outsourced process, and unparalleled service. Auxilio's target market includes medium to large hospitals and health care systems. Customers served by Auxilio include health systems such as Saint Barnabas Medical Center, Scottsdale Healthcare, St. Joseph Health System, MemorialCare and Huntington Hospital.

For more information, see the company's website at www.auxilioinc.com.

Forward-Looking Information

This release contains certain forward-looking statements relating to the business of Auxilio, Inc. that can be identified by the use of forward-looking terminology such as "believes," "expects," or similar expressions. Such forward-looking statements involve known and unknown risks and uncertainties, including uncertainties relating to product development, efficacy and safety, regulatory actions or delays, the ability to obtain or maintain patent or other proprietary intellectual property protection, market acceptance, physician acceptance, third party reimbursement, future capital requirements, competition in general and other factors that may cause actual results to be materially different from those described herein as anticipated, believed, estimated or expected. Certain of these risks and uncertainties are or will be described in greater detail in our filings with the Securities and Exchange Commission, which are available at http://www.sec.gov. Auxilio, Inc. is under no obligation (and expressly disclaims any such obligation) to update or alter its forward-looking statements whether as a result of new information, future events or otherwise.



            

Contact Data